Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma

por Hijazi, Youssef, Klinger, Matthias, Kratzer, Andrea, Wu, Benjamin, Baeuerle, Patrick A., Kufer, Peter, Wolf, Andreas, Nagorsen, Dirk, Zhu, Min
Publicado 2018

Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL

por Nägele, Virginie, Kratzer, Andrea, Zugmaier, Gerhard, Holland, Chris, Hijazi, Youssef, Topp, Max S., Gökbuget, Nicola, Baeuerle, Patrick A., Kufer, Peter, Wolf, Andreas, Klinger, Matthias
Publicado 2017

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes

por Eriksson, Olof, Haack, Torsten, Hijazi, Youssef, Teichert, Lenore, Tavernier, Veronique, Laitinen, Iina, Berglund, Jan Erik, Antoni, Gunnar, Velikyan, Irina, Johansson, Lars, Pierrou, Stefan, Wagner, Michael, Tillner, Joachim
Publicado 2020